The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index; 13 of the 48 sources its claims cite were checked for support.
Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice
Open accessAbstract
The bidirectional interactions between the gut microbiota and sepsis-associated encephalopathy (SAE) are not well characterized. We found that the gut microbiota was more severely disturbed in SAE-susceptible (SES) mice than in SAE-resistant (SER) mice after sepsis modeling.
Overview
CoChat Summary
TL;DR
Sepsis-induced gut dysbiosis differs between cecal ligation and puncture (CLP) mice that are susceptible versus resistant to sepsis-associated encephalopathy (SAE), and transferring susceptible feces worsens neuroinflammation. The microbial metabolite indole-3-propionic acid (IPA) is enriched in resistant mice and protects against CLP-induced anxiety, memory impairment, and microglial NLRP3/IL-1β activation, possibly via the aryl hydrocarbon receptor.
Key findings
- Mice with a neurological score ≤6 at 36 h after CLP were defined as SAE-susceptible (SES), while those with a score >6 were SAE-resistant (SER); SER mice had better survival, and SES mice showed greater anxiety, worse mobility, and higher serum/cortical IL-1β and TNF-α.
- Gut microbiota was more disrupted in SES mice: SES mice had lower Shannon and higher Simpson indices than SER mice, with Enterobacteriaceae enriched in SES and Bacteroidia/Bacteroidota/Bacteroidales enriched in SER.
- Fecal microbiota transplantation showed that all mice receiving SES feces died within 48 h, whereas survival was 40% for CON-FMT recipients and 30% for SER-FMT recipients; SES-FMT recipients also had higher serum and cortical IL-1β and TNF-α.
- IPA was enriched in feces and serum of SER mice; IPA treatment improved survival, neurological scores at 36, 48, and 72 h, reduced anxiety and spatial memory impairment, lowered IL-1β, and inhibited LPS-induced NLRP3, cleaved caspase-1, and IL-1β in primary microglia; the AhR antagonist CH223191 attenuated these effects.
Methods
- Male C57BL/6 mice (6–8 weeks old) underwent CLP or sham surgery; neurological scores, survival, open field, and Morris water maze tests were used, with tissues collected at 36 h or later.
- Gut microbiota was analyzed by 16S rRNA gene sequencing, PCA, LEfSe, and PICRUSt; nontargeted metabolomics measured fecal metabolites, and serum IPA was measured after antibiotic depletion and fecal gavage.
- FMT was performed after 5 days of antibiotic treatment, followed by 3 days of donor feces gavage; IPA was given by gavage at 25 mg/kg, and primary microglia were treated with LPS, IPA (0.5 or 1.0 mM), and/or CH223191 (10 μM), with Western blotting, ELISA, and immunofluorescence. Statistical analysis used Student’s t test or ANOVA, with P < 0.05 considered significant.
Limitations
- Stated: no antibiotics were used in the IPA delivery experiments, so additional microbiota-produced IPA could not be excluded; whether IPA reduces bacteremia is unclear; AhR-knockout mice were not used to confirm that IPA affects survival via AhR in microglia.
- Evident from the text: findings are from a mouse CLP model only, with no human validation, and several experiments used small samples (e.g., n = 6 to 10 for FMT and n = 4 to 5 for microglia assays).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
8 Valid · 0 Not valid · 25 Not checked · 92 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Patients with sepsis exhibit severe disruptions in the gut microbiota profile for various reasons, such as the use of broad-spectrum antibiotics (14, 15).”
§ Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice > INTRODUCTION
What the sources say
- Supportedcites [14] Liu Z, Li N, Fang H, Chen X, Guo Y, Gong S, Niu M, Zhou H, Jiang Y, Chang P, Chen P. 2019. Enteric dysbiosis is associated with sepsis in patients. FASEB J 33: 12299– 12310. doi: 10.1096/fj.201900398RR. 31465241 PMC6902702 source
The Abstract reports that gut microbiota composition was significantly disrupted in patients with sepsis compared with healthy individuals, and the Results document lower diversity and distinct microbial communities. The Results also note that antibiotic treatment affects intestinal microbiota, though the paper does not specify broad-spectrum antibiotics. (LLM, conf=0.91)
- Supportedcites [15] Adelman MW, Woodworth MH, Langelier C, Busch LM, Kempker JA, Kraft CS, Martin GS. 2020. The gut microbiome's role in the development, maintenance, and outcomes of sepsis. Crit Care 24: 278. doi: 10.1186/s13054-020-02989-1. 32487252 PMC7266132 source
In “Sepsis worsens gut microbiome disruption,” the paper reports decreased gut microbiome diversity in patients with sepsis, increased abundance of potentially pathogenic bacteria, and loss of beneficial commensals. The same section identifies antibiotics as a major driver of sepsis-related microbiome alteration. Page numbers are not provided in our copy. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Previous studies have indicated that susceptibility to organ injury, especially in the brain, could be modulated by the intestinal microbiota (9–11).”
§ Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice > INTRODUCTION
What the sources say
- Not checked yetcites [9] Gong S, Yan Z, Liu Z, Niu M, Fang H, Li N, Huang C, Li L, Chen G, Luo H, Chen X, Zhou H, Hu J, Yang W, Huang Q, Schnabl B, Chang P, Billiar TR, Jiang Y, Chen P. 2019. Intestinal microbiota mediates the susceptibility to polymicrobial sepsis-induced liver injury by granisetron generation in mice. Hepatology 69: 1751– 1767. doi: 10.1002/hep.30361. 30506577 source
- Partly supportedcites [10] Hu J, Luo H, Wang J, Tang W, Lu J, Wu S, Xiong Z, Yang G, Chen Z, Lan T, Zhou H, Nie J, Jiang Y, Chen P. 2017. Enteric dysbiosis-linked gut barrier disruption triggers early renal injury induced by chronic high salt feeding in mice. Exp Mol Med 49: e370. doi: 10.1038/emm.2017.122. 28857085 PMC5579512 sourceExperimental — accuracy not yet measured
The Results section reports that changing the gut microbiota altered early renal injury in mice, supporting the general point that microbiota can modulate susceptibility to organ injury. The paper does not show modulation of brain injury; its Discussion mentions a gut–brain-axis study only in connection with cytokine expression and gut-barrier disruption during autism development. No page numbers are available in our copy. (LLM, conf=0.87)
- Partly supportedcites [11] Cryan JF, O'Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE, Jaggar M, Long-Smith CM, Lyte JM, Martin JA, Molinero-Perez A, Moloney G, Morelli E, Morillas E, O'Connor R, Cruz-Pereira JS, Peterson VL, Rea K, Ritz NL, Sherwin E, Spichak S, Teichman EM, van de Wouw M, Ventura-Silva AP, Wallace-Fitzsimons SE, Hyland N, Clarke G, Dinan TG. 2019. The microbiota-gut-brain axis. Physiol Rev 99: 1877– 2013. doi: 10.1152/physrev.00018.2018. 31460832 sourceExperimental — accuracy not yet measured
The Innate Immune System section describes microbiota–microglia interactions as a mechanism affecting brain inflammation and discusses responses to tissue damage. This supports a possible role for intestinal microbiota in brain responses, but the passages do not establish that it modulates susceptibility to organ injury generally, or directly demonstrate susceptibility to brain injury. (LLM, conf=0.78)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“These studies indicated that the gut microbiota may be an upstream regulator of SAE, which is consistent with our findings.”
- Also stated in: § Conclusions. · hedged
“In summary, by associating a microbial metabolite, IPA, as a neuroprotective compound, our study suggests that the gut microbiota is an upstream regulator of SAE and that the variability in sepsis-induced gut dysbiosis mediates the differential susceptibility to SAE in CLP-induced experimental sepsis mice.”
§ Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice > DISCUSSION
What the sources say
- Not checked yetcites [18] Li S, Guo H, Xu X, Hua R, Zhao Q, Li J, Lv J, Li J. 2021. Therapeutic methods for gut microbiota modification in lipopolysaccharide-associated encephalopathy. Shock 56: 824– 831. doi: 10.1097/SHK.0000000000001758. 33595259 source
- Supportedcites [24] Chen L, Qing W, Yi Z, Lin G, Peng Q, Zhou F. 2021. NU9056, a KAT 5 inhibitor, treatment alleviates brain dysfunction by inhibiting NLRP3 inflammasome activation, affecting gut microbiota, and derived metabolites in LPS-treated mice. Front Nutr 8: 701760. doi: 10.3389/fnut.2021.701760. 34327209 PMC8313765 source
The Introduction states plainly that 'Intestinal flora and metabolic disorders are also major factors in the deterioration of SAE' and that probiotics 'may improve the cognitive impairment of SAE mice by regulating the gut microbiota', i.e. the microbiota acts upstream of the brain dysfunction. The Discussion reinforces this with the 'microbiota-gut-brain axis' framing and 'Increasing evidence has shown that inflammation, BBB function, and cognitive dysfunction in SAE mice provide a key link to gut microbiota and metabolism', concluding that NU9056 'might attenuate SAE by regulating the gut microbiota'. The hedged claim ('may be an upstream regulator') matches the source's own speculative/hedged level, though the source's supporting data in LPS-treated mice are largely correlational (genus-level correlations with SCFAs and IL-1beta/IL-6, Results 'Gut Microbiota Was Related to SCFA and Inflammatory Factors'). (LLM, conf=0.82)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Conclusions. · hedged
Every source the paper cites for this claim was checked and supports it.
In the paper
“The aryl hydrocarbon receptor (AhR) has been shown to negatively regulate NLRP3 inflammasome activity (21).”
§ Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice > RESULTS > Indole-3-propionic acid inhibited the activation of the NLRP3 inflammasome in lipopolysaccharide-stimulated microglia.
What the sources say
- Supportedcites [21] Huai W, Zhao R, Song H, Zhao J, Zhang L, Zhang L, Gao C, Han L, Zhao W. 2014. Aryl hydrocarbon receptor negatively regulates NLRP3 inflammasome activity by inhibiting NLRP3 transcription. Nat Commun 5: 4738. doi: 10.1038/ncomms5738. 25141024 source
The Discussion states that AhR inhibited NLRP3 inflammasome formation and caspase-1 activation. The study summary also identifies AhR as a negative regulator of NLRP3 inflammasome activity; the claim accurately paraphrases this finding. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recent studies suggest that IPA may control microglia-activated inflammation through a mechanism mediated by AhR (29, 37).”
§ Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice > DISCUSSION
What the sources say
- Partly supportedcites [29] Rothhammer V, Mascanfroni ID, Bunse L, Takenaka MC, Kenison JE, Mayo L, Chao CC, Patel B, Yan R, Blain M, Alvarez JI, Kebir H, Anandasabapathy N, Izquierdo G, Jung S, Obholzer N, Pochet N, Clish CB, Prinz M, Prat A, Antel J, Quintana FJ. 2016. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 22: 586– 597. doi: 10.1038/nm.4106. 27158906 PMC4899206 sourceExperimental — accuracy not yet measured
In Results (‘Dietary tryptophan limits CNS inflammation via AhR’; page unavailable), IPA is identified as an AhR agonist, and IPA supplementation reduced EAE scores and inflammatory-marker expression in astrocytes. Results (‘AhR expression in astrocytes limits CNS inflammation’; page unavailable) also report that astrocytic AhR signaling regulates microglial activation. The paper does not directly show that IPA controls microglia-activated inflammation; the IPA experiment measures astrocyte markers and disease scores. (LLM, conf=0.84)
- Partly supportedcites [37] Rothhammer V, Borucki DM, Tjon EC, Takenaka MC, Chao CC, Ardura-Fabregat A, de Lima KA, Gutierrez-Vazquez C, Hewson P, Staszewski O, Blain M, Healy L, Neziraj T, Borio M, Wheeler M, Dragin LL, Laplaud DA, Antel J, Alvarez JI, Prinz M, Quintana FJ. 2018. Microglial control of astrocytes in response to microbial metabolites. Nature 557: 724– 728. doi: 10.1038/s41586-018-0119-x. 29769726 PMC6422159 sourceExperimental — accuracy not yet measured
The passage on dietary tryptophan metabolites (section labelled Abstract; page unavailable) reports that I3S limits pro-inflammatory programs in microglia through AHR. It does not identify or test IPA as that metabolite; in the Methods, IPA instead abbreviates Ingenuity Pathway Analysis. The AHR-mediated mechanism is supported, but the IPA-specific claim is not. (LLM, conf=0.86)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
74 more claims · 2 with their cited sources checked
Create a free account to see all 125 claims and to verify the 35 references still open.
- Probably not a substantial claim. 21
- It may state two separate claims as one. 28
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Molecular mechanisms involve: (1) Butyrate activates the GPR109A/Nrf2/HO-1 pathway [106]; (2) Indolepropionic acid (IPA) inhibits the NLRP3 inflammasome and IL-1β secretion [107]; (3) NU9056 upregulaes SCFA levels to antagonize inflammasome activity [108].”
From Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy (2026) · cites this paper as [107]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice > RESULTS > Indole-3-propionic acid protected mice against CLP-induced SAE and death.
“Open field tests showed a significant increase in the duration spent in the center and the ratio of the center distance to the total distance of IPA-treated mice compared with that of saline-treated mice.”
§ Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice > RESULTS > Indole-3-propionic acid protected mice against CLP-induced SAE and death.
“(C) Results of the open field test performed for SES and SER mice on day 2 after CLP.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice > RESULTS > Enrichment of indole-3-propionic acid in feces from SER mice.
“the IPA levels partially reverted after administration of feces from healthy mice (Fig. 3F).”
§ Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice > RESULTS > Enrichment of indole-3-propionic acid in feces from SER mice.
“(F) Serum IPA levels. n = 6 to 7.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice > RESULTS > Indole-3-propionic acid inhibited the activation of the NLRP3 inflammasome in lipopolysaccharide-stimulated microglia.
“(B, C) Mouse primary microglia were pretreated with different concentrations of IPA (IPAL, 0.5 mM; IPAH, 1.0 mM) for 1 h and stimulated with LPS for 12 h.”
§ Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice > MATERIALS AND METHODS > Primary culture of microglia and treatment.
“followed by LPS (1 μg/mL) stimulation for 6 h.”
Citations
Cites
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286 · cited 2×
“Indole-3-propionic acid (IPA) is a metabolite that was found to be neuroprotective in previous studies (11).”
BackgroundSurviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Swanson, K. V., Deng, M., & Ting, J. P.-Y. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0165-0 · Cited by 4,884 · cited 2×
“Sufficient NLRP3 protein expression is essential for NLRP3 inflammasome formation and activation (20).”
BackgroundRothhammer, V., Mascanfroni, I. D., Bunse, L., Takenaka, M. C., Kenison, J. E., Mayo, L., Chao, C.-C., Patel, B., Yan, R., Blain, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4106 · Cited by 1,559 · cited 14×
“The aryl hydrocarbon receptor (AhR) has been shown to negatively regulate NLRP3 inflammasome activity (21).”
BackgroundResultInfluentialRothhammer, V., & Quintana, F. J. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0125-8 · Cited by 1,197 · cited 1×
“AhR, a ligand-dependent transcription factor, can be activated by diverse ligands including indole-based compounds (22, 23).”
BackgroundMicroglial control of astrocytes in response to microbial metabolites
Rothhammer, V., Borucki, D. M., Tjon, E. C., Takenaka, M. C., Chao, C.-C., Ardura-Fabregat, A., de Lima, K. A., Gutiérrez-Vázquez, C., Hewson, P., Staszewski, O., et al. (2018) · Nature · doi:10.1038/s41586-018-0119-x · Cited by 1,051 · cited 11×
“The aryl hydrocarbon receptor (AhR) has been shown to negatively regulate NLRP3 inflammasome activity (21).”
BackgroundInfluentialThe Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Extreme Dysbiosis of the Microbiome in Critical Illness
McDonald, D., Ackermann, G., Khailova, L., Baird, C., Heyland, D., Kozar, R., Lemieux, M., Derenski, K., King, J., Vis-Kampen, C., et al. (2016) · mSphere · doi:10.1128/msphere.00199-16 · Cited by 426 · cited 1×
“Induction of gut dysbiosis in septic patients has been previously reported (25, 26).”
BackgroundThe gut microbiome’s role in the development, maintenance, and outcomes of sepsis
Adelman, M. W., Woodworth, M. H., Langelier, C., Busch, L. M., Kempker, J. A., Kraft, C. S., & Martin, G. S. (2020) · Critical Care · doi:10.1186/s13054-020-02989-1 · Cited by 342 · cited 1×
“ous reasons, such as the use of broad-spectrum antibiotics (14, 15).”
BackgroundPotentially modifiable factors contributing to sepsis-associated encephalopathy
Sonneville, R., de Montmollin, E., Poujade, J., Garrouste-Orgeas, M., Souweine, B., Darmon, M., Mariotte, E., Argaud, L., Barbier, F., Goldgran-Toledano, D., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4807-z · Cited by 323 · cited 1×
“bances are more susceptible to SAE (8).”
Research works printed but not linked: 1
- Wei R, Chen X, Hu L, He Z, Ouyang X, Liang S, Dai S, Sha W, Chen C. 2021. Dysbiosis of intestinal microbiota in critically ill patients and risk of in-hospital mortality. Am J Transl Res 13:1548–1557.
Cited by
Surviving Sepsis Campaign Research Priorities 2023
Backer, D. D., Deutschman, C. S., Hellman, J., Myatra, S. N., Ostermann, M., Prescott, H. C., Talmor, D. S., Antonelli, M. M., Azevedo, L. C. P., Bauer, S. R., et al. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006135 · Cited by 201
“Reports in animal models of sepsis indicate that microbiota metabolites modulate outcomes (231–233) and implicate the gut microbiome in injury in multiple organs (234, 235).”
BackgroundZhou, Y., Chen, Y., He, H., Peng, M., Zeng, M., & Sun, H. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109690 · Cited by 153
The central role of the gut in intensive care
Corriero, A., Gadaleta, R. M., Puntillo, F., Inchingolo, F., Moschetta, A., & Brienza, N. (2022) · Critical Care · doi:10.1186/s13054-022-04259-8 · Cited by 92
“Unbalanced molecular communication contributes to neurodegenerative and neuropsychiatric diseases [23], traumatic brain injury (TBI) [24], and sepsis-correlated brain impairment [25, 26].”
BackgroundResultXu, J., & Lu, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1583562 · Cited by 93
Self-citationJiang, J. W., Wang, D., Jiang, Y., Yang, X., Sun, R., Chang, J., Wenhui, Z., Yao, P., Song, K., Chang, S., et al. (2024) · Microbiome · doi:10.1186/s40168-024-01755-7 · Cited by 63
“…IPA on cognitive memory deficits stemming from neurodevelopmental anomalies in either humans or animals is relatively constrained, IPA, functioning as a potent neuroprotective agent, has already exhibited its capacity to ameliorate spatial memory impairments induced by cecal ligation puncture [65].”
Self-citation
Metadata
- Authors
- Fang, H., Wang, Y., Deng, J., Zhang, H., Wu, Q., He, L., Xu, J., Shao, X., Ouyang, X., He, Z., Zhou, Q., Wang, H., Deng, Y., & Chen, C.
- Affiliations
- Guangdong Academy of Medical Sciences (CN)
- Dalian Medical University (CN)
- Corresponding author
- Deng, Yiyu
- Chen, Chunbo
- ORCID
- Venue
- mSystems
- Publisher
- American Society for Microbiology
- Published
- 2022-06-28
- Volume
- 7
- Issue
- 3
- Pages
- e0139921-e0139921
- ISSN
- 2379-5077 (ISSN-L)
- PMC
- PMC9239149
- OpenAlex
- W4281935887
- Cited by
- 87
- References
- 39
- Citations by year
- 2026: 20 · 2025: 28 · 2024: 22 · 2023: 15 · 2022: 2
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mSystems (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Science and Technology Program of Guangzhou City (201803010058)
- Maoming Science and Technology Project (2020255)
- Guangdong Province High-level Hospital Construction Project of Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciencesl (DFJH2020028)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- sepsis-associated encephalopathy, gut microbiota, gut dysbiosis, neuroinflammation, NLRP3 inflammasome, IL-1β, microglia, aryl hydrocarbon receptor, sepsis susceptibility, fecal microbiota transplantation, neuroprotection
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Neuroinflammatory Diseases, Animals, RNA, Ribosomal, 16S, Sepsis, Mice, Inflammasomes, Dysbiosis, Sepsis-Associated Encephalopathy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice. https://app.cochat.ai/papers/10.1128/msystems.01399-21
- The paper
- Fang, H., Wang, Y., Deng, J., Zhang, H., Wu, Q., He, L., Xu, J., Shao, X., Ouyang, X., He, Z., Zhou, Q., Wang, H., Deng, Y., & Chen, C. (2022). Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice. mSystems. https://doi.org/10.1128/msystems.01399-21
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.